NTRA Natera, Inc. Earnings per share growth rate in current year

Official company branding of natera.com (NTRA)

Natera, Inc. (NTRA) is exposed to raw material supply chain disruption risks stemming from global conflicts. Business success relies on insurance coverage for tests and patent protection. Growth is driven by internal R&D and partnerships with oncology centers. The current level of the indicator is -5.10, which is detailed by the relative EPS YoY price action.

NTRA - Natera Medical Earnings per share growth in current year over the range 07/04/2022 - 11/16/2026

Comprehensive metric breakdowns and analytics for Natera, Inc. (NTRA)

- current quotes and average value forecast:
Fundamental valuation:NTRA Natera Medical
Manufactured product of Natera Medical

This metric measures the annual trend of earnings per share, reflecting the efficiency of net income generation relative to total capital. By analyzing the annual EPS change, an investor assesses the ability of Natera, Inc. (NTRA) to monetize its patents and genetic data assets amidst fierce competition with laboratory behemoths, which confirms the resilience of its market advantage.